We evaluated the Resident Assessment Instrument-Mental Health (RAI-MH) assessment platform at a large psychiatric hospital in Ontario during the 3 years following its provincially mandated implementation in 2005. Our objectives were to document and consider changes over time in front-line coding practices and in indicators of data quality.
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Clinical Implications
• The RAI-MH-based assessment system, as implemented and used in nonresearch conditions in a diverse array of services, showed variable performance in supporting outcome monitoring.
• Symptom underreporting may be a limiting factor for these assessment data.
Limitations
• The data come from a single psychiatric hospital.
• Findings are preliminary until replicated in other facilities or until broader system-level initiatives documenting and evaluating frontline coding practices can be undertaken.
C linical assessment is integral to quality health care.
It forms the basis of care planning and outcome monitoring, and yields information essential for equitable resource allocation and system planning. Since 2005, the RAI-MH has provided the platform for client assessment in Ontario's adult inpatient mental health sector. 1, 2 The RAI-MH is comprised of about 400 items addressing current and past mental health symptoms, psychosocial and behavioural functioning, comorbidities, and service provision. Its objectives include care planning, outcome monitoring, quality improvement, and resource allocation. 1 In Ontario, the provincial government mandates that the RAI-MH be completed at admission, quarterly throughout hospitalization, at changes in clinical status, and at discharge for all episodes of inpatient care among adults admitted to designated psychiatric beds. Generating provincewide information within and across episodes over time, the RAI-MH offers a potentially rich resource for system planning, facility and regional comparisons, and clinical research. Because it represents one in a suite of compatible instruments that provide standardized data across various health and social service settings, capacity exists for crosssector analyses. 3, 4 The target administration time of the RAI-MH is 60 to 75 minutes. 1, 2, 5 Clinicians are directed to consult various sources, from client self-report to observation, medical records, and family members. Summary measures include MHAPs (recently renamed Clinical Assessment Protocols 6 ), outcome scales, quality improvement indicators, and algorithms for resource allocation. Our evaluation focused on the first 2 types of summary measures because of their greater familiarity to clinicians. About 30 MHAPs identify client needs and provide guidance for care planning. 4 The 10 outcome scales, many of which are adapted from other versions of the RAI-MH, 7-10 assess client symptoms and functioning. 2 Also embedded are the GAF 11 and the CAGE-AID scale. 12, 13 Psychometric research suggests acceptable to good reliability and validity of many of the RAI-MH items and summary measures. [4] [5] [6] However, because of its systemwide application and influence over clinical and policy decision-making, the RAI-MH's performance in real-world contexts (for example, administered by multiple clinicians in diverse settings) is also of interest. To accomplish its objectives, the RAI-MH needs to be not only reliable and valid as a measurement tool but also feasible, relevant, and transferable across settings. Pragmatic evaluation of performance and user experiences remains an important area of inquiry related to, but distinct from, traditional psychometric research. This kind of work considers implementation of the assessment platform as a whole, and is not strictly limited to the RAI-MH tool per se. That is, performance on clinical front lines is also impacted by details of the provincial mandate (for example, what data are mandated at a given assessment point and the time frame allotted for reporting), as well as the infrastructure in place to assist clinicians with entering and using the data (for example, electronic software and linkages between related information systems). There is a dearth of systematic evaluation of the performance of the RAI-MH on clinical front lines in Ontario and elsewhere.
We aimed to evaluate the capacity of the RAI-MH-based assessment system to support its objectives of care planning and outcome monitoring through structured interviews réexaminer la pertinence du RAI-MH pour les soins des toxicomanies en milieu hospitalier. Les questions de conformité et de motivation du personnel et les problèmes de rendement du système d'évaluation seraient étroitement liés, ce qui rend inutile de tenter d'attribuer à l'un ou à l'autre la responsabilité des domaines d'un rendement loin d'être optimal. La capacité du RAI-MH d'avoir un bon rendement en première ligne clinique est, dans tous les cas, essentielle pour atteindre ses objectifs. L'évaluation continue de cette plateforme d'évaluation devrait être prioritaire pour la future recherche. with clinical stakeholders and a retrospective review of assessment data at a large psychiatric and addiction treatment facility. Our objectives were to document and consider changes over time in coding practices and data quality.
Methods
Setting
The evaluation was conducted at CAMH, located in downtown Toronto, Ontario. In a given year, about 3800 inpatient care episodes are registered across 8 clinical services. CAMH has used the RAI-MH since pilot testing in 2002.
Data Collection and Analysis. Prior to the retrospective data review, we conducted interviews with front-line clinicians and clinical managers (n = 9) across the organization. This information-gathering exercise focused on the diversity of assessment issues across different types of services and highlighted areas to target in the data review. We sought interviews from people most familiar with their program's use of the RAI-MH. Using transcripts of the recordings and interviewer notes, responses were tabulated for each question, separately, by 2 project members. Common themes and program-specific issues were identified by a single analyst, and participants were given the opportunity to review the results to ensure these accurately reflected their experiences.
Drawing from themes highlighted in the interviews, we selected 5 quantitative indicators of data quality (Table  1) . These covered an array of issues expected to be of interest to clinicians, researchers, and policy-makers. The first 2 indicators considered evolution in data quality from the year preceding the provincial mandate (enacted in November 2005) through the next 2 calendar years. Remaining indicators drew from admission and discharge assessments in 2007 to minimize the impact of any initial implementation challenges. Reviews of the employment items, MHAPs and scale scores were conducted at the assessment level (including multiple admissions per client) as this accurately reflected the analytic purpose of describing assessment properties. In the cross-program comparisons, data from one program serving people with developmental disorders were excluded owing to the small number of clients. External validation of data on co-occurring SUDs was conducted at the individual level (excluding multiple admissions per client) to permit comparison with published estimates. Correlations between RAI-MH scales and GAF scores were also calculated at the individual level to preserve observation independence. For clients with multiple admissions during the year, the first episode was selected. Activities were approved by the CAMH Research Ethics Board.
Results
Front-line Coding Practices. Several themes arose from the interviews with staff. These included variability across programs, missing data and underreporting, time constraints, and shortcomings in relevance and scope.
Variability Across Programs. Programs varied in the frontline practices used to gather and enter RAI-MH data. All participants acknowledged that nursing staff carry primary responsibility for assessment; however, there was variation in the extent to which allied professionals (for example, social workers and occupational therapists) were also involved. Concerns were voiced over accuracy of the assessment conducted solely by nurses. In some programs, data-gathering and coding occurred through section delegation to different disciplines, while in others, discussions in team meetings were used to obtain consensus over client needs. One program reported that admission assessments were wholly client-reported.
Missing Data and Underreporting. Programs varied in the degree to which they seek out information from different sources, and in the effort they expend to fill in missing data. All participants acknowledged underreporting, particularly at admission, given the short time frame for reporting (that is, 72 hours). It was hoped that accuracy improved over time for long-stay clients. Some difficulties were reported in obtaining psychiatric diagnoses and GAF ratings from psychiatrists in time for the admission assessments. When unavailable, these would be entered or corrected at discharge; however, this information was reported to be obtained from nurses in some units. Accurate reporting of medical diagnoses was noted to be challenging owing to difficulties in obtaining the information and in locating diagnostic terms in the electronic interface.
Time Constraints. Estimates of the time required to conduct the admission assessment was 20 to 45 minutes, although this varied depending on whether nurses were able to sit undisturbed for a sufficient period of time. All participants reported the time burden as contributing to staff dissatisfaction with the assessment. Some noted that this likely impacted on data quality and wondered whether shortened versions were possible for particular programs or time points.
Shortcomings in Relevance and Scope. All but one participant felt that the RAI-MH provided an incomplete description of the issues facing their clients, making additional assessment necessary. Different reasons were reported for this. One participant reported that the tool reflected a medical model of care mismatched to their program's recovery orientation.
Another saw the assessment as well-designed for longterm services, but inadequate for shorter-term specialized care for less severely impaired clients. The interviewees with addictions expertise felt that it was particularly inadequate for assessment in their services. Although all participants were positive on the use of the MHAPs for care planning, they also noted that the MHAPs could be too sensitive and identified issues not relevant to the current episode. Participants almost universally reported that lack of relevance was a complaint voiced by front-line staff.
All reported that many of their staff view the RAI-MH as a mandatory administrative task, rather than a useful clinical tool.
Data Completeness and Quality
Items With Consistently Low Yield. Across all 4 of the selected programs and in all 3 years, items assessing extrapyramidal symptoms, services, control procedures, nutrition, and gambling were endorsed in fewer than 5% of assessments. The greatest number of low-yield items was found in the addictions program. In addition to the above content, these included items assessing psychosis, behavioural disturbance, impaired cognition, ADL, communication problems, and bladder or bowel functioning.
Internal Validation of Data Quality. In 2005 only, a proportion of people with no income were reported to be receiving an income from various sources (ranging from 3% for employment insurance, to 29% for social assistance), or were categorized as employed (3%). In all 3 years, 23% to 29% of people with an employment income were categorized as unemployed, and 21% to 24% of people who were employed were classified as ineligible for items assessing unemployment risk.
External Validation of Data Quality. In 2007, 24% of clients on mental health units had a provisional co-occurring SUD at admission. However, only 12% screened positive on the CAGE-AID (that is, endorsed 2 or more items), including only 36% of people with an SUD.
Yield of MHAPs in Identifying Needs. The pattern of MHAPs triggered across programs in 2007 admission assessments largely conformed to expectations based on program focus and clientele ( Table 2) . For example, violence was most common in the LAMH, while abuse by others was relatively higher in the Women's program and addictive behaviours was unanimously triggered in the Addictions program. Three MHAPs were rarely triggered (less than 5%) across multiple programs: bladder and bowel functioning, and polydipsia.
Yield and Variation in Scale Scores. As with the MHAPs, the pattern of differences in scale means across programs largely conformed to expectations (Table 3) . Although there was some variability across programs, score distributions were generally heavily negatively skewed and showed a preponderance of zeros, reflecting the absence of impairment at admission. In the Addictions program, the mean on 7 of 10 scales fell below 1.0, and the proportion with a score of zero exceeded 95% for 5 scales. Other notable findings included means of 1.8 on the Positive Symptom Scale in the Schizophrenia program, and 3.1 for the Depression Rating Scale in the Mood and Anxiety program. For the latter, only 45.7% of assessments received a score of 3 or more, indicating possible depression. 2 In contrast, mean IADL impairment in the Geriatric program was centred in the range of possible values, at 17.1 out of a possible 30. Most scale distributions covered the full range of possible values; although many still showed limited average variability. For instance, the hierarchical ADL scale had an average variation of less than 1.0 in all but the Geriatric program, meaning that clients tended to differ from one another by less than 1 category on this 7-point ordinal scale. At the program level, mean change scores were also heavily centred at zero, showing limited change within episodes, and with low average variability across episodes (Table 4 ).
Average GAF scores at admission indicated moderate-toserious impairment (that is, 40 to 60; Table 3 ), and signalled variable levels of improvement during treatment ( Table 4 ). Each of the RAI-MH scales was inversely associated with the GAF in at least one program; although these associations were small to modest in value ( Table 5 ).
Discussion
Our study contributes to the literature on psychiatric clinical assessment and complements existing psychometric research on the RAI-MH by examining performance under nonresearch conditions. Through a retrospective data review, we have empirically highlighted both successes and areas for improvement. In so doing, our work provides valuable information on the institutional evolution of clinical assessment practices and offers an empirical perspective for ongoing dialogue. Although the assessment platform has continued to evolve since the evaluation, our work covered an important period leading up to and following the provincial mandate, and following several years of institutional experience with the RAI-MH.
Findings suggest improved data quality over time. The electronic interface has no doubt played a role here, by disallowing discordant responses. The relative ease and flexibility offered by automatic data checks warrants their expansion, and findings highlight remaining opportunities, such as for employment status and co-occurring medical disorders. High quality, system-level data on these indicators may make substantial contributions to the literature, as these are topics of current research interest. [14] [15] [16] [17] Co-occurring SUDs are equally highly relevant to mental health research, clinical practice, and system planning. 18 The RAI-MHbased estimate of 24% for co-occurring disorders across inpatient mental health programs at CAMH is comparable with that reported elsewhere when chart review is used, but lower than that found with diagnostic interview. 19, 20 At the program level, most MHAPs contributed information to the assessment process, providing preliminary empirical support for the RAI-MH's capacity to meet its objective of care planning. The perception that some MHAPs were overly sensitive is consistent with a recent international validation study. 4 Based on that study, recommendations were made for MHAP deletion and refinement, including differentiating clients based on expected outcomes. The MHAPs triggered most infrequently in the validation study matched those triggered most infrequently in our study at CAMH.
Balancing these positive findings were ongoing challenges and concerns voiced by interviewees. Rather than constituting a full qualitative study of clinical assessment practices, the interviews were conducted to obtain information on how the RAI-MH was actually completed on clinical front lines and to support proper interpretation of results from the quantitative review. Our concern lay not in obtaining a representative sample of clinicians, but in exploring heterogeneity in challenges and successes across the array of inpatient services at the hospital. Findings highlighted numerous concerns that warrant further study, including potential underreporting and shortcomings in relevance and scope. Given the small sample size, further research is needed to determine the representativeness of these concerns.
Evidence regarding the RAI-MH objective of outcome monitoring varied across programs, but was not particularly encouraging. Aggregated to the program level, the scales appeared to capture little impairment at baseline. Many also indicated a low ability to discriminate between clients at admission and over time. As a result of low scores at admission, the level of change captured between admission and discharge did not seem to reflect the improvement one would expect to see during a psychiatric hospitalization. The RAI-MH includes a series of scales so that psychopathology in the entire treatment population is covered. Although the component items, being targeted and specific, identify symptoms and trigger MHAPs for care planning, most of the resulting outcome scales are irrelevant for most patients. This can be true even within a specialty program (for example, patients admitted to a mood disorders program with a diagnosis of mania would not be expected to score high on a scale assessing depression symptomatology).
In formal reporting to government bodies, data from the RAI-MH scales are reported only for those who are symptomatic on a given scale at admission. Ultimately, however, the inability to provide a common measure of clinical severity and functioning across a heterogeneous clinical sample is problematic for the purposes of outcome evaluation and research. Viewed in this manner, the RAI-MH outcome scales appear to be at a disadvantage relative to other dimensional measures that capture global impairment and demonstrate change with treatment (for example, the Behavior and Symptom Identification Scale-32 [21] [22] [23] [24] or the Short Form-36 [25] [26] [27] [28] ).
A recent paper 2 cites cut-off values for many of the RAI-MH scales, suggesting that their intended use may be as categorical indicators, rather than dimensional measures.
The reasons for this approach should be articulated, as categorization has other implications (for example, reduced statistical power to detect change over time, and compromised reliability and validity). 29, 30 The empirical basis and clinical meaning of the cut-off values should also be made explicit. For instance, in our study, it is concerning that fewer than one-half of assessments in the Mood and Anxiety program scored above the threshold for possible depression on the Depression Rating Scale. Further investigation is warranted to verify whether this finding is unique to CAMH, reflects clients admitted with other diagnoses such as mania, or signals an issue with content and scaling.
Within the confines of our study, it is not possible to determine whether the low scores on the outcome scales stemmed from data-collection issues, such as underreporting, or from patient-level heterogeneity in clinical presentation within programs. Even within programs, an array of factors Cognitive Performance Scale
Changes in Health, End-Stage Disease, and Signs and Symptoms contributes to the decision to admit someone, and these may not be captured by symptom counts. Concurrently, interviewees expressed concerns regarding underreporting, particularly at admission. Replication in other facilities would be useful in clarifying whether these scale properties are unique to CAMH. Additional work should also examine the match between program inputs and expected outcomes, such as would be reflected in a program logic model. 31 This would help to clarify whether there are potential opportunities for streamlining the assessment. The use of modern measurement theory and computerized adaptive testing may support the development of abbreviated versions without reducing validity, and would parallel broader efforts at improving the efficiency of clinical assessment. 32, 33 Such efforts would likewise be useful in addressing perceptions of administrative burden and dissatisfaction among frontline clinical staff. Studies have documented the negative impacts of lengthy assessment protocols and provider burden on data quality, supporting the need to maximize the efficiency of assessment procedures. 32 The impact of specific data-gathering and -entry practices on data quality also deserves further evaluation.
Interviewees perceived a positive impact on data quality through multidisciplinary involvement (compared with nursing only) and team assessments. Front-line practices will unavoidably be tailored to fit the clinical setting. For instance, it is difficult to envision how a short-term program with a high volume of clients would implement group assessments at their team meetings. Systematic evaluation of different assessment practices would provide empirical evidence for contextually appropriate procedures, to support clinical staff and ensure meaningful data for system planning and resource allocation.
Findings suggest that the assessment platform may be better suited to longer-term services for severely impaired clients, than to acute or addiction services. In particular, use of the RAI-MH in hospital-based addictions care should be revisited. The lack of content assessing psychosocial consequences of substance use, addiction recovery processes and outcomes, and the existence of a separate mandated assessment package in Ontario, 34 all question the use of the RAI-MH in these settings. Within the addictions-focused content, the CAGE-AID is not designed to assess severity or change over time in substance-related outcomes. 12, 13 Limitations Although these data were collected at a key point in the evolution of the RAI-MH at the hospital, this work should be updated to reflect trends in data quality since 2008. In addition, findings represent the experiences of a single facility, and generalizability to other facilities remains a question for future research. That said, CAMH houses a diverse array of inpatient settings, ranging from short-term, highly specialized services to longer-term services for patients with chronic and severe impairment. Given the provincial mandate, reporting requirements are also standardized across Ontario. Ultimately, broader system-level initiatives focused on documenting and evaluating front-line coding practices are needed.
Conclusions
As would be expected, our evaluation documented both positives and negatives regarding the performance of the RAI-MH-based assessment system. Although data quality improved over time, findings suggest that the capacity of the platform to support outcome monitoring requires further attention. It is tempting in the face of such results to allocate responsibility for areas of less than optimal performance, either to the assessment platform or to issues of staff motivation and compliance. Such conclusions are not possible within the confines of these data, and may be misleading in any case. Problems with the assessment platform and issues with staff compliance would be highly interrelated, and the ability of the RAI-MH to perform well on clinical front lines is essential for it to meet its objectives. Evaluation provides clinicians and administrators with an opportunity for reflection on clinical assessment practices and supports ongoing dialogue around performance and quality improvement. At a broader systems level, highquality data are needed to support evidence-based planning and policy. Continued evaluation of this assessment platform should be a priority for future research.
